MYDA Advisors LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.

Quarter-by-quarter ownership
MYDA Advisors LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$729,600
-13.8%
80,0000.0%0.24%
-7.1%
Q2 2023$846,400
+246.0%
80,000
+300.0%
0.25%
+173.1%
Q1 2023$244,600
-1.5%
20,0000.0%0.09%
-39.2%
Q4 2022$248,200
-9.1%
20,0000.0%0.15%
+19.5%
Q3 2022$273,000
-25.6%
20,0000.0%0.13%
+24.3%
Q2 2022$367,000
+14.0%
20,0000.0%0.10%
-18.9%
Q1 2022$322,00020,0000.13%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders